Clinical Trials Browser

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Chondrosarcoma, Chordoma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Osteosarcoma, Neurofibrosarcoma

NCT07215832 2026-03-02

KEAP

Available

GynecologicLymphoidMyeloidPlasma cellSarcoma

Multiple Myeloma, Sarcoma, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral, Endometrial Neoplasms, Primary Myelofibrosis

NCT06617572 2026-02-09

Expanded Access Protocol (EAP) for Nonconforming (NC) Afami-cel

Available

Sarcoma

Sarcoma, Synovial, Liposarcoma, Myxoid

NCT07262970 2025-12-04

Intermediate-Size Cohort EAP for Ersodetug in Patients With Inadequately Controlled Hypoglycemia Related to a Tumor

Available

EndocrineNETSarcoma

Fibrosarcoma, Hyperinsulinism, Hypoglycemia, Insulinoma, Adenoma, Islet Cell, Liposarcoma, Neoplasms, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors

NCT05974410 2025-10-02

Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients

Available

BreastCNSGastrointestinalGenitourinaryGynecologicLymphoidSarcoma

Brain Neoplasms, Breast Neoplasms, Carcinoma, Squamous Cell, Glioblastoma, Hodgkin Disease, Lymphoma, Non-Hodgkin, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms

Clinical Trials

Expanded Access to Bezuclastinib to be Coadministered With Sunitinib for Patients With Gastrointestinal Stromal Tumors

Individual Patient Compassionate Use of Nirogacestat

Compassionate Use of Ubamatamab

Expanded Access Use of L-MTP-PE for the Treatment of Osteosarcoma

BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast

KEAP

Expanded Access Protocol (EAP) for Nonconforming (NC) Afami-cel

Intermediate-Size Cohort EAP for Ersodetug in Patients With Inadequately Controlled Hypoglycemia Related to a Tumor

Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients

Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors

131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young Adults

Expanded Access of Vigil in Solid Tumors

Expanded Access to Everolimus, for an Individual Patient With GIST (Gastrointestinal Stromal Tumors)(CTMS#18-0019)

Expanded Access Program (EAP) Designed to Provide Access to Botensilimab and Balstilimab Before Regulatory Approval

Olaratumab (LY3012207) Patient Access for Soft Tissue Sarcoma

Expanded Access Program for Avapritinib

Tazemetostat Expanded Access Program for Adults With Epithelioid Sarcoma

Tazemetostat Expanded Access Program for Adults With Solid Tumors

Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies

Catequentinib in Patients Who Have Completed an Advenchen Study (A Compassionate Use Trial)

Early Access Program (EAP) for Avapritinib in Patients With Locally Advanced Unresectable or Metastatic GIST

Expanded Access Program of Ripretinib (DCC-2618) for the Treatment of Patients With Advanced GIST

Single Patient Expanded Access to Ganitumab for Metastatic Ewing Sarcoma

Compassionate Use Protocol for PF-03084014 in Patients With Advanced Solid Tumor Malignancies

A Study to Provide Access to Trabectedin in Participants With Locally Advanced or Metastatic Soft Tissue Sarcoma Who Have Persistent or Recurrent Disease and Who Are Not Expected to Benefit From Currently Available Standard of Care Treatment

SARC021C: A Continuation Study of TH-CR-406/SARC021

Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy (Managed Access Program)

Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease

Compassionate Use of Aldoxorubicin in Sarcoma Patients Chemotherapy

MACS2226

Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy

Treatment Protocol of Voraxaze for Patients Experiencing or at Risk of Methotrexate Toxicity

YONDELIS (Trabectedin) Single Patient Compassionate Use / Expanded Access